Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Euro Log Regulatory News (ASLI)

Share Price Information for Abrdn Euro Log (ASLI)

Share Price is delayed by 15 minutes
Get Live Data
18.74    0.42 (2.29%)
Bid:
18.60
Ask:
18.78
Spread: 0.18 (0.968%)
Market Cap: £77.24m
ASLI Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Euro Log Share Chart

B Share Scheme First Distribution

27 Feb 2025 07:00

RNS Number : 6065Y
abrdn European Logistics Income plc
27 February 2025
 

27 February 2025

LEI: 213800I9IYIKKNRT3G50

 

abrdn European Logistics Income plc

B Share Scheme first distribution

27 February 2025 - abrdn European Logistics Income plc (the "Company" or "ASLI"), the Company invested in a diversified portfolio of European logistics real estate now in managed wind-down, announces details of its first capital distribution under the shareholder approved B Share Scheme.

Introduction

On 24 January 2025, the Company announced that it had concluded the sale of the freehold of the 12,384 square metre warehouse located in Oss, The Netherlands, for a consideration of €15.7 million. Following the completion of the transaction, the Company paid down €9.9 million of the outstanding €44.2 million debt, which is cross collateralised with Ede and Waddinxveen, provided by Berlin Hyp.

The Company also announced the sale of two assets located in Spain concluded in January for an aggregate consideration of €29.7 million. Of the net proceeds from the sale of these two Spanish properties, €17.7 million was applied in paying down a portion of the €51 million ING Bank secured debt, which is cross collateralised with Gavilanes, Madrid, Unit 4 and occupied by Amazon, reducing the Company's gearing further to €218 million with an all-in interest rate of 1.93%.

Following these disposals, the repayment of debt and the movement of funds up to the parent from SPVs, the Board has resolved to make a first capital distribution to Shareholders under the shareholder approved B Share Scheme of the net sales proceeds now available totalling approximately £16.5 million.

Approved B Share Scheme

B Shares will be allotted and issued to Shareholders pro rata to their holdings of Ordinary Shares as at the record date for the issue of the B Shares. The Company will not allot or issue any fractions of B Shares and entitlements of each Shareholder will be rounded down to the nearest whole B Share. The B Shares have only very limited rights. The rights and restrictions attached to the B Shares are fully set out in Part 3 of the Company's circular which was issued on 6 November 2024. Shareholders can find full details on the Company's website at www.abrdn.com/en-gb/asli under the Literature section.

No share certificates will be issued for any B Shares allotted and no CREST accounts will be credited with any such shares. No application will be made for the B Shares to be admitted to listing on the Official List or to trading on the London Stock Exchange's main market for listed securities and the B Shares will not be listed or admitted to trading on any other recognised investment exchange.

B Shares will be issued and redeemed by the Company's registrar, Equiniti. Each redemption of B Shares will be undertaken at the option of the Company. It is expected that redemption will occur shortly after each date of issue and allotment of B Shares, when all of the B Shares then in issue will be compulsorily redeemed and cancelled in accordance with their terms for an amount not exceeding the amount treated as paid up on the B Shares.

Following the redemption and cancellation of the B Shares, the redemption proceeds will be sent to Shareholders either through CREST to uncertificated Shareholders or via cheque to certificated Shareholders.

Initial B Share Scheme Distribution

Pursuant to the authority received from Shareholders at the general meeting held on 22 November 2024, the Board has resolved to return approximately £16.5 million in aggregate to Shareholders via an issue of B Shares.

B Shares of one penny each will be paid up from the Company's special distributable reserve, created by the recent cancellation of the share premium account, and issued to all Shareholders by way of a bonus issue on the basis of 4 B Shares for every 1 Ordinary Share held at the Record Date of 6.00 p.m. on 6 March 2025. The ex date is 5 March 2025.

The B Shares will be issued on 7 March 2025 and immediately redeemed at one penny per B Share. The Redemption Date in respect of this B Share issue is therefore 7 March 2025. The proceeds from the redemption of the B Shares, which is equivalent to 4 pence per Ordinary Share, will be sent to uncertificated Shareholders through CREST or via cheque to certificated Shareholders.

NOTE: NO SHARE CERTIFICATES WILL BE ISSUED IN RESPECT OF B SHARES

 

Timetable for the Initial Return of Capital

It is expected that the timetable will be as follows:

2025

Ex Date in respect of the Initial Return of Capital

5 March

Record Date in respect of the Initial Return of Capital

6 p.m. on 6 March

Issue and allotment of B Shares in respect of the Initial Return of Capital

7 March

Redemption Date in respect of the Initial Return of Capital

7 March

Payment date: (i) cheques posted to Shareholders; and (ii) CREST holders credited with funds, in each case in respect of the Initial Return of Capital

20 March

 

Defined terms used in this announcement have the meanings given in the Circular published by the Company on 6 November 2024 which may be found on the Company's website unless the context otherwise requires.

 

Enquiries:

abrdn Fund Managers Limited

Ben Heatley +44 (0) 20 7156 2382

Investec Bank plc +44 (0) 20 7597 4000

David Yovichic

Denis Flanagan

FTI Consulting +44 (0) 20 3727 1000

Dido Laurimore

Richard Gotla

Oliver Parsons

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEDFAMEISESE
Date   Source Headline
5th Oct 20227:00 amRNSPurchase of warehouses in France & the Netherlands
28th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:05 amRNSUnaudited NAV as at 30 June 2022
22nd Aug 20227:00 amRNSSecond Interim Distribution
10th Aug 20227:00 amRNSWaddinxveen Extension and Lease Signing
1st Aug 20221:09 pmRNSAlternative Investment Fund Manager Change of Name
1st Aug 20227:00 amRNSProperty Acquisition – Dachser France
6th Jun 20223:52 pmRNSResult of AGM
30th May 20227:00 amRNSUnaudited Q1 2022 NAV and Company Update
27th May 20224:35 pmRNSPublication of a Supplementary Prospectus
24th May 20227:00 amRNSFirst Interim Dividend
11th May 202210:15 amRNSDoc re. Annual report
22nd Apr 20227:00 amRNSAnnual Financial Report
15th Mar 202210:14 amRNSHolding(s) in Company
10th Mar 20225:40 pmRNSUpdate research from QuotedData
1st Mar 202212:26 pmRNSTotal Voting Rights
22nd Feb 20227:00 amRNSUnaudited Net Asset Value as at 31 December 2021
18th Feb 20222:23 pmRNSFourth Interim Distribution
4th Feb 202211:56 amRNSDirector/PDMR Shareholding
4th Feb 202211:53 amRNSDirector/PDMR Shareholding
4th Feb 202211:52 amRNSDirector/PDMR Shareholding
4th Feb 202211:50 amRNSDirector/PDMR Shareholding
2nd Feb 20227:00 amRNSResult of Placing and Retail Offer
12th Jan 20227:01 amRNSPrimaryBid Offer
12th Jan 20227:00 amRNSProposed Placing Under Share Issuance Programme
5th Jan 20224:11 pmRNSChange of name
14th Dec 20217:00 amRNSEUR227m Acquisition of Madrid Warehouse Portfolio
13th Dec 20214:47 pmRNSHolding(s) in Company
9th Dec 20215:36 pmRNSHolding(s) in Company
7th Dec 20215:18 pmRNSHolding(s) in Company
23rd Nov 20214:10 pmRNSThird Interim Dividend
19th Nov 20217:00 amRNSUnaudited Net Asset Value as at 30 September 2021
1st Nov 202111:00 amRNSTotal Voting Rights
21st Oct 20217:00 amRNSGRESB 2021 Survey Results
11th Oct 202111:30 amRNSDoc re: Half Yearly Report
7th Oct 20214:59 pmRNSHolding(s) in Company
5th Oct 20214:00 pmRNSDirector/PDMR Shareholding
5th Oct 20214:00 pmRNSDirector/PDMR Shareholding
5th Oct 20213:58 pmRNSDirector/PDMR Shareholding
5th Oct 20213:58 pmRNSDirector/PDMR Shareholding
30th Sep 202111:33 amRNSResult of General Meeting
30th Sep 20217:00 amRNSHalf-year Results
29th Sep 20212:10 pmRNSResult of Oversubscribed Initial Issue
21st Sep 20215:25 pmRNSUpdate research from QuotedData
8th Sep 20214:04 pmRNSPublication of Prospectus and Circular
8th Sep 20217:00 amRNSLaunch of Issue
19th Aug 20217:00 amRNSQ2 2021 NAV and Second Interim Dividend
12th Jul 20217:00 amRNSAcquisition and Portfolio Update
8th Jun 20217:00 amRNSAGM Results
24th May 20212:34 pmRNSQ1 2021 NAV and First Interim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.